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ABSTRACT 
Background and Objectives: The emerging use of endovascular therapies for acute 
ischemic stroke, the preferred being intra-arterial thrombectomy, requires a better 
understanding on the anesthetic management needed and its impact in treatment 
outcomes. This article reviews the available data on the anesthetic approach of 
endovascular treatment, comparing general anesthesia with conscious sedation, the 
most used modalities, in terms of time of anesthesia induction and procedure time, 
patient mobility, location of the occlusion, hemodynamic parameters, outcome and 
safety; it also focuses on the state of the art on physiologic and pharmacologic 
neuroprotection. 
Contents: Most of the evidence on this topic is retrospective and contradictory, with 
only one randomized study to date. Conscious sedation was frequently associated with 
better outcomes, but the prospective evidence declared that it has no advantage over 
general anesthesia concerning that issue. Conscious sedation is at least as safe as 
general anesthesia for the endovascular treatment of acute ischemic stroke, with no 
higher mortality and fewer complications like pneumonia, hypotension or extubation 
difficulties. It has, however, a higher frequency of patient agitation and movement, 
which is the main cause for conversion to general anesthesia. 
Conclusions: General anesthesia and conscious sedation are both safe alternatives as 
anesthetic management of patients submitted to endovascular thrombectomy. No 
anesthetic approach is universally recommended and hopefully the ongoing randomized 
clinical trials will shed some light on the best method; meanwhile, the choice of 
anesthetic should be based on the patient’s individual characteristics. Regarding 
neuroprotection, meeting hemodynamic targets is currently the most important strategy, 
as no pharmacological method has been proven effective in humans. 
 
Keywords: anesthesia; anesthesia, general; conscious sedation; stroke; thrombectomy; 
endovascular procedures; neuroprotection 
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INTRODUCTION 
Acute ischemic stroke (AIS) is one of the leading causes of mortality and morbidity 
worldwide1, 2 and its significant burden has driven the scientific research in its treatment 
options. 
Intravenous recombinant tissue plasminogen activator (IV rtPA) has been the 
standard treatment for AIS since 1996, when it was approved by the Food and Drug 
Administration. Endovascular therapy has recently emerged as a supplement to IV rtPA 
or eventually as a plausible alternative to the standard treatment for patients not eligible 
for it; it was included in the 2015 American Heart Association/American Stroke 
Association updated guidelines for the early management of AIS. There are two 
endovascular approaches: intra-arterial fibrinolysis or intra-arterial thrombectomy (with 
a multitude of devices available); the preferred is the intra-arterial thrombectomy with a 
stent retriever.3 
A key factor plays a part in both treatments: time. The concept of “time is brain” – 
meaning that nervous tissue in the penumbra region of reduced blood flow in the brain 
is not salvageable after a few hours – has long been known, and a shorter period of time 
between symptom onset and reperfusion is associated with better clinical outcomes.4 In 
the particular case of endovascular therapy, time to groin puncture should be less than 
6 hours.3 The anesthetic management needed for the endovascular treatment of AIS 
plays a role in the timing of initiation of the procedure, hence the need for a better 
understanding of the impact of the anesthetic choice in treatment outcomes. 
General anesthesia (GA) and conscious sedation (CS) are the two most used 
modalities for patients with AIS undergoing intra-arterial thrombectomy. Each has 
potential advantages and limitations: general anesthesia is thought to be associated with 
less agitation and movement but may delay the beginning of the endovascular 
procedure; conscious sedation permits neurological monitoring but may induce pain and 
movement, making the procedure longer and more difficult. Some studies also include a 
monitored anesthesia care approach or even local analgesia alone. 
The lack of randomized prospective information on this topic dictated that practice 
was based on retrospective studies, meta-analysis and surveys. The Society of 
Neuroscience in Anesthesiology and Critical Care (SNACC) consensus gave some general 
recommendations on anesthetic management and hemodynamic goals, based on the 
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available evidence at the time.5 However, a substantial number of trials are now 
ongoing6-9 and the results from one randomized study have been published.10 This article 
reviews the available data on the anesthetic approach of intra-arterial thrombectomy, 
comparing general anesthesia with conscious sedation in terms of time of anesthesia 
induction and procedure time, patient mobility, location of the occlusion, hemodynamic 
parameters, outcome and safety; it also focuses on the state of the art on 
neuroprotective strategies. 
 
METHODS 
Literature search of articles comparing general anesthesia and conscious sedation 
on endovascular treatment of acute ischemic stroke was conducted up to February 2017 
using the following databases: MEDLINE (via Pubmed), Web of Science and 
clinicaltrials.gov.  A combination of the following search terms was used: stroke, 
anesthesia, thrombectomy, endovascular, conscious sedation, general anesthesia. 
Additionally, the references of various articles were examined to find studies which 
did not appear in the initial search. 
 
GENERAL ANESTHESIA VERSUS CONSCIOUS SEDATION 
General anesthesia is generally regarded as a safe anesthetic approach for the 
endovascular treatment of AIS, mainly because of patient immobility, absence of pain, 
airway control (with presumed less risk of intraprocedural aspiration) and optimal control 
of oxygenation and carbon dioxide levels. The main disadvantages appointed to this 
method are increased induction time (time from symptom onset to groin puncture), 
hypotension and greater blood pressure fluctuations, complications of intubation 
(pneumonia and sepsis), more difficult postanesthetic recovery, and a greater need of 
qualified anesthesiologists, which assumes greater costs.5, 11-14  
Conscious sedation, on the other hand, permits monitoring during the procedure for 
new neurological deficits and has less iatrogenic hemodynamic variation and less delay 
to the start of the intervention, yet it has risks of patient pain, agitation and movement 
with possible vessel perforation, upper airway obstruction, respiratory depression, 
increased procedure time with increased use of contrast and possible emergency 
conversion to GA.5, 11-15 
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The majority of retrospective studies and also the ongoing clinical trials compare 
these anesthetic modalities not only in terms of outcome but also procedure duration, 
patient mobility, hemodynamic parameters such as blood pressure and overall safety. 
These will be reviewed in more detail. Table I (Enter Table I) contains a summary of 
most studies’ conclusions. 
 
1. Time to groin puncture and procedure time 
For every minute a great vessel AIS goes untreated, 1.9million neurons and 13.8 
billion synapses are lost.4 Treatment of AIS is an emergency and the sooner it is initiated, 
the better the possible outcome; this is why a delay in time from symptom onset to groin 
puncture is a major concern in patients undergoing endovascular treatment managed 
with GA. In one study, this delay was found to be of 15 minutes, comparing with CS15; 
in another study, it was of 20 minutes.12 While some scientists do worry about this delay 
and found it related to worse outcomes in GA compared to CS12, others considered that 
this relatively short delay occurring with GA seems to be tolerable considering that GA 
allows the procedure to be performed under optimal conditions, avoiding delays during 
the treatment itself, which may be far longer if there is patient movement, as it 
sometimes occurs in awake patients.15 John et al. indeed describe a longer time of 
induction and intubation but a shorter time from incision to target vessels with GA, with 
a global time from symptom onset to recanalization similar between groups.16 
One study with 980 patients found no significant differences in time to puncture and 
time to recanalization between CS and GA, but the authors still consider that a delay in 
GA not demonstrated by their methods might account for some differences in outcome.17  
Schönenberger et al., in the only randomized controlled trial to date, describe a gain 
of 10 minutes when using CS, although no differences in outcome came from that.10 
 
2. Patient mobility 
Patient mobility is the major problem regarding CS and one of the main reasons 
many physicians prefer GA - a survey conducted in 2010 among 68 members of the 
Society of Vascular and Interventional Neurology revealed that more than half the 
respondents preferred GA as their anesthetic method of choice, under the assumption 
that limited movement correlates with more safety and efficacy.11  
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Patient mobility and agitation can be related to pain, which can be due to the 
innervation of the blood vessels which are being manipulated17 or to the transmission of 
tension to the dura matter15. If the patient moves, it can affect fluoroscopy and digital 
subtraction angiography, increasing the difficulty of the procedure and the risk of 
complications, such as vessel perforation and brain hemorrhage.17 Some researchers, 
however, report very low rates of wire perforation during percutaneous coronary 
interventions in which the heart is constantly moving18, affirming that perforation in 
endovascular treatments might not be primarily caused by movement.17 
Nonetheless, perforation and cervical carotid dissection were unexpectedly more 
frequent in the GA group in Jumaa et al. study, a finding the authors admit could be due 
to chance.14  
Janssen et al. studied the applicability of a standard cervical collar for head 
immobilization in order to reduce risks with CS, which seemed to also have a calming 
effect on patients; the outcomes were favorable.19  
Patient movement may even be a cause for emergent conversion to GA, being the 
main cause for the conversion rates ranging between 2,7% to 3,7% in various studies12, 
14, 20; other motive of conversion was emesis, with greater risk of aspiration. Hassan et 
al. studied conversion in various types of neuroendovascular procedures and reported a 
global conversion rate from CS to GA of 1,7% (9 in 526 patients), which was not related 
to worse outcomes than the group managed with GA from the beginning.20  
   
3. Affected circulation 
Endovascular treatment with stent retrievers might be appropriate for AIS caused 
by occlusion of the M2 or M3 portion of the middle cerebral arteries, anterior cerebral 
arteries, vertebral arteries, basilar artery, or posterior cerebral arteries3.  
Posterior circulation occlusion causes 15% to 20% of all AIS; basilar artery occlusion 
is a subset of posterior AIS, causing only 1% to 4% of all AIS.21 When the basilar artery 
is the occluded vessel, patients usually have changes in level of consciousness.14 SNACC 
recommends the use of GA in posterior circulation stroke, as they frequently cannot 
protect the airway (Class IIa, Level of evidence B).5 There is a lack of studies comparing 
CS and GA on specific territories and most of them do not focus on posterior circulation 
AIS, excluding these patients because they are almost exclusively managed with GA.14, 
16, 17  
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4. Hemodynamic parameters – Blood pressure 
The ischemic penumbra area is highly sensitive to variations in blood pressure (BP). 
As AIS impairs cerebral autoregulation, hypertension and hypotension can cause edema 
and hemorrhage or infarct extension, respectively, adversely impacting the outcome.22, 
23 The SNACC consensus recommends a systolic target of 140-180 mmHg (a study 
associates this range with better outcomes23) and a diastolic blood pressure below 105 
mmHg; hypotension should be avoided using fluids and vasopressors (Class IIa, Level 
of evidence B)5. Vasopressors commonly used are epinephrine, norepinephrine, 
phenylephrine or ephedrine24, 25, but the choice should depend on the patient’s individual 
characteristics.5  
Hypotension is frequent after the induction of GA25-27 and may diminish perfusion of 
the penumbra area by collateral vessels, therefore impairing recovery.28  
Hendén et al. retrospectively studied 108 patients managed with GA for 
endovascular treatment of AIS, hypothesizing that intraprocedural hypotension was an 
independent predictor for poor neurological outcomes. In their study, the mean BP was 
107 mmHg and almost all patients had a drop in BP during the procedure, with 69 
patients (63,8%) falling more than 40% from baseline. It was this mean arterial BP fall 
of more than 40% from baseline that the authors found to be an independent predictor 
of poor neurologic outcomes. They also suggest that vasopressors should be 
administrated during induction of GA, after correcting possible hypovolemia with fluids 
and heart failure with inotropic agents.28  
More than a drop in BP, Chung et al. indicate BP variability as independently and 
linearly associated with neurologic deterioration in AIS.29 Mundiyanapurath et al. 
identified a greater BP variability in patients treated under GA, apart from lower mean 
systolic BP values with episodes of hypotension (systolic BP<100mmHg) requiring 
vasopressors like norepinephrine.25   
A study of 190 patients by John et al. , nevertheless, found no significant differences 
in hemodynamic variables between GA and monitored anesthesia care.16 
Schönenberger’s prospective trial also showed that the mean systolic BP and the 
variability of systolic BP were not significantly different between GA and CS, which 
contradicts most of the retrospective evidence.10  
Sivasankar et al. observe that the diversity of findings concerning blood pressure 
may be due to differences in dosage of anesthetics or sedatives.24  
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5. Outcome 
Albeit a general preference of GA by practitioners, recent retrospective studies pose 
CS as an equally safe alternative and even related with better outcomes.12, 14, 17, 30 
Juma et al. study of 126 patients described an independent association with 
favorable outcomes of not only age, admission NIHSS score and successful 
recanalization, but also of CS, which was also related to favorable radiographic 
outcomes.14  
Nichols et al. did not compare specifically CS to GA, but also found that lower levels 
of sedation were independently associated with good clinical outcomes and successful 
reperfusion and that heavy sedation or pharmacological paralysis were a predictor of 
mortality.31 This was also true for a study comparing GA with a non-anesthetized 
approach.32 
John et al. revealed similar rates of recanalization, but patients managed with GA 
had lower associations with good outcomes (not statistically significant).16  
Contrasting with recent retrospective evidence, the first randomized trial in this area 
determined that CS was not superior to GA in the management of endovascular 
treatment of AIS, with early neurological improvement similar in both groups.10  
A study by Sivasankar et al. offered a different perspective on the anesthetic 
management of endovascular treatment, stating that different methods of general 
anesthesia (volatile, intravenous or combined) may have different outcomes; in their 
study, patients with better outcomes were managed with volatile drugs only. The authors 
criticize the study of non-characterized general anesthesia and sedation, suggesting that 
future investigation should well-defined anesthetic agents.24  
 
6. Safety/Complications 
Complications during endovascular treatment of AIS can be divided in two groups: 
complications of the procedure itself and complications related to the anesthetic 
management. The most serious complication is cerebral hemorrhage., which can be 
symptomatic or not. Stent retrievers are related to a frequency of symptomatic 
intracerebral hemorrhage between 1.5% and 15%, as reported by recent trials.5  
As patients are awake in CS, new or worsening neurological deficits can be assessed 
during the procedure and the endpoint of treatment can be based on clinical 
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improvement and not only on angiographic recanalization. Deficits may be attributable 
to decreases in local blood flow due to embolization, thrombus formation, progression 
of ischemic area or hematoma.17 This intraprocedural monitoring is one of the 
advantages of  CS, but John et al. point out that a stroke patient frequently has acute 
neurologic deficits and may be disphasic, which can largely limit the communication with 
the physician, hampering intra-procedural questioning.33  
Procedure-related complications are vessel perforation with intracranial hemorrhage 
(symptomatic or asymptomatic), arterial dissection, distal embolization and problems 
related to the access site, like groin or retroperitoneal hematomas.31 When grouping the 
various trials in the area, total complications rates were 0%-20% and 1%-6% when only 
considering embolization, dissection and perforation.34 
Abou-Chebl et al. found no difference in posttreatment intracranial bleeding.17 John 
et al. also did not find differences in hemorrhagic transformation of the stroke between 
GA and monitored anesthesia care, but GA managed patients had a higher rate of 
parenchymal hematomas.16 
Complications of the anesthetic management are aspiration, pneumonia, blood 
pressure lability, patient movement and upper airway obstruction. There are some 
complications specifically attributed to intubation in GA, like pneumonia (aspiration and 
ventilator-related) and extubation difficulties. AIS patients have certain characteristics 
that can add to a higher risk of pneumonia, like diminished airway reflexes, relaxation 
of pharyngeal muscles, hypovolemia and dysphagia.35  
Jumaa et al. documented a longer ICU stay, primarily due to difficulties in weaning 
the patients off the ventilation, and a higher rate of early pneumonia in patients managed 
with GA. Their main conclusion was that CS was at least as safe as GA for endovascular 
treatment.14 
The rate of pneumonia was also higher in GA group in two other studies31, 35; Hassan 
et al.35 hypothesized that the higher rate of pneumonia was responsible for poorer 
outcomes with GA, but concluded that pneumonia was not the major reason for that. 
Additionally, intubation is more related to withdrawal of care than CS, accounting for 
a part of the increased mortality of patients managed with GA.14 This higher mortality of 
the deeply sedated patients, related or not to the discontinuation of therapy, is reported 
by various studies16, 17, 30, 31, 36-39. 
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Schönenberger et al. reported no differences in in-hospital and overall mortality 
between the two groups, but complications like hypothermia, delayed extubation and 
pneumonia were more frequent in patients managed with GA.10  
 
NEUROPROTECTION 
Cerebral neuroprotection aims to improve the brain’s tolerance to ischemia, 
protecting neurons and other components of the cerebral system.40 This can be done by 
maintaining the blood flow in the penumbra area, decreasing metabolic demand or 
diminishing the deleterious effects of mediators released by cell death.41 It is regarded 
as a set of measures complementary to reperfusion in AIS which theoretically can be 
started in the prehospital setting, possibly extending the time window to subsequent 
treatments.42  
Some pharmacological agents have shown neuroprotective properties in animal 
experiments and other preclinical trials, but human studies results have been 
controversial and unsatisfactory.43 An example is magnesium sulfate, which was tested 
in a cardiac and non-cardiac setting, showing neuroprotective effects in both43, 44, and it 
was also neuroprotective in animal models of stroke.42 However, it did not improve 
disability outcomes at 90 days after stroke in a phase 3 trial.42 
Currently, there is not a single agent with proven neuroprotective properties in 
humans. Intravenous anesthetics such as thiopental (a barbiturate), propofol, ketamine, 
lidocaine and etomidate, and the inhalational anesthetics isoflurane, desflurane, 
sevoflurane, xenon and argon are some of the agents that have been studied, with 
inconclusive results so far.43 
Other methods of neuroprotection aside from pharmacological neuroprotection, such 
as hypothermia, are being studied. Hypothermia is an established therapy for cardiac 
arrest and hypoxic ischemic encephalopathy in children, it has been shown to be 
neuroprotective in laboratory animal models of AIS45, and has had promising results in 
preliminary trials46; nonetheless, it has yet to be definitely proven beneficial in human 
studies.47, 48 The SNACC consensus does not recommend hypothermia, proposing a 
target temperature of 35-37ºC, maintained with antipyretics and cooling devices if 
needed (Class IIb, Level of evidence B).5 
Surely, maintaining the hemodynamic parameters within the normal values is an 
important component of neuroprotection. Besides body temperature and arterial BP, 
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referred above, oxygenation, ventilation and glycemic values are also considered in the 
SNACC consensus. Logically, hypoxia should be avoided, and recommendations are that 
supplemental oxygen should be considered and that FiO2 should be titrated to keep 
SpO2>92% and PaO2>60mmHg (Class IIa, Level of evidence C).5 
Hyperventilation and hypocapnia can cause cerebral vasoconstriction, therefore 
reducing the cerebral blood flow and having an adverse impact on the penumbra area. 
The evidence points towards a correlation between GA and hypocapnia, with lower end 
tidal carbon dioxide (ETCO2) being associated with worse outcomes.26 Surprisingly, in 
Mundiyanapurath et al. study, patients under CS had a lower ETCO2 related to 
hyperventilation; the investigators admit the possibility of a performance bias or a 
limitation in the method of measuring end-tidal CO2 in non-intubated patients.25 Thus, 
in patients intubated and managed with GA, ventilation should be regulated to maintain 
normocapnia (PaCo2 between 35 and 45 mmHg)(Class IIa, Level of evidence C).5 
Glucose values should be maintained between 70 and 140mg/dL (Class IIa, Level of 
evidence C), with intravenous insulin treatment of hyperglycemia of >140mg/dL (Class 
IIb, Level of evidence C)5 and correction of hypoglycemia of <50mg/dL (Class IIa, Level 
of evidence C) with intravenous dextrose or infusion of 10% or 20% glucose,49 this being 
the only indication for fluids containing dextrose. 
 
DISCUSSION 
As the main body of evidence on the anesthetic management of AIS endovascular 
treatment is retrospective, there is a lot of controversy on the subject. Most studies’ 
limitations are their non-prospective and non-randomized nature17, limited number of 
subjects14, 31 and selection bias12, 16, with some having major differences in stroke severity 
between the groups - GA managed patients have higher baseline NIHSS scores in most 
studies.14, 17, 31  
In 2014, the SNACC published a consensus intended to offer some guidance to the 
clinicians involved in the endovascular treatment of AIS, presenting various targets for 
variables like BP, oxygenation, ventilation and glucose values. Regarding the anesthetic 
techniques, the general recommendation was that the choice of agent should be 
individualized to the clinical setting; more specific recommendations on one agent over 
the other did not have a strong class of recommendation (Class IIa) or a high level of 
evidence (Level B-C).5 This translates the need for well-designed randomized controlled 
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clinical trials which can produce more reliable data. Although some trials are currently 
ongoing, only one has published results so far.  This study is not without limitations: the 
fact that it is a single-center study with a sample of only 150 patients, treated by a very 
specialized staff with vast experience in general anesthesia, might have influenced the 
results.10 The conclusions of other prospective trials published in the next few years will 
reinforce or contradict the actual evidence that both approaches are equally safe.  
Meanwhile, as the ideal anesthetic approach for the endovascular treatment of AIS 
remains unknown, the choice of agent should continue to be individualized, weighting 
the benefits and risks and considering local protocols, personal preferences and 
experience of the physicians.11, 12, 17 Some situations, like inability to protect the airway, 
lack of cooperation and decreased consciousness, will always require GA.16 On other 
conditions, the small conversion rate of conscious sedation to general anesthesia might 
support the use of conscious sedation as the initial anesthetic method.10 
 
CONCLUSION 
The trend towards considering CS as better than GA in terms of outcome might 
change with recent evidence, as the first randomized trial did not confirm this 
hypothesis.10 CS is at least as safe as GA for the endovascular treatment of AIS, with no 
higher mortality and fewer complications like pneumonia; as the rate of conversion to 
GA is small, CS might be used as the initial approach in a variety of cases not demanding 
GA. Essentially, the anesthetic method should always be individualized based on the 
clinical characteristics of the patient5 and no method is currently officially recommended. 
The apparent shorter time to initiate the procedure and higher patient mobility with CS, 
the higher risk of hypotension and BP variability with GA and the affected circulation 
should be considered. 
Regarding neuroprotection, the most important strategy is to maintain the 
hemodynamic parameters between the recommended targets. As for pharmacological 
neuroprotection, no agent has been proven effective to date. 
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GLOSSARY 
AIS – Acute Ischemic Stroke 
BP – Blood Pressure 
CS – Conscious Sedation 
ETCO2 – End Tidal Carbon Dioxide 
FiO2 – Fraction of inspired Oxygen 
GA – General Anesthesia 
ICU – Intensive Care Unit 
IV rtPA – Intravenous recombinant tissue plasminogen activator 
NIHSS - National Institutes of Health Stroke Scale 
PaCo2 – Partial pressure of Carbon dioxide in the blood 
PaO2 - Partial pressure of Oxygen in the blood 
SNACC - Society of Neuroscience in Anesthesiology and Critical Care 
SpO2 - Oxygen Saturation 
 
 
Table I - Summary of the anesthetic approach in cited studies 
 
Study Type N 
Affected 
circulation 
Anesthetic 
approach Outcomes 
Limitations reported by the 
investigators 
Abou-Chebl 
[17] 
2010  
Retrospective, 
multicentric 
(12 centers) 980 
Anterior 
circulation 
large-vessel 
occlusion 
strokes GA vs CS 
GA associated with: 
- poorer neurological outcome 
at 90 days 
- higher mortality 
No difference in hemorrhagic 
complications 
• Retrospective and non-
randomized nature 
• GA - more likely to have 
carotid terminus occlusions 
and higher baseline NIHSS 
scores 
Abou-Chebl 
[38] 
2015 
Retrospective, 
multicentric 
(58 centers; 
cohort from 
IMS III trial) 434 
Anterior, 
middle and 
posterior 
circulation 
strokes GA vs LA 
GA associated with: 
- worse neurological outcomes 
- increased mortality 
• Retrospective and non-
randomized nature 
• LA - lower NIHSS scores 
Abou-Chebl 
[37] 
2014  
Retrospective, 
multicentric 
(18 centers) 281 
Anterior and 
posterior 
circulation 
strokes GA vs LA 
GA associated with: 
- worse neurological outcomes 
- higher mortality 
No difference in risk of 
intracranial hemorrhage 
• Retrospective and non-
randomized nature 
• LA - lower NIHSS scores 
Jumaa [14] 
2010 
Retrospective, 
monocentric 126 
Occlusion of 
the M1 
segment of 
the middle 
cerebral artery 
Intubated (IS) vs 
Non-intubated 
(NIS) 
IS associated with: 
- greater final infarct volume 
- worse outcomes 
- higher in-hospital mortality 
• Retrospective and non-
randomized nature 
• Small sample size 
• IS - higher baseline 
NIHSS scores 
van den Berg 
[12] 
2015 
Retrospective, 
multicentric 
(16 centers; 
cohort from 
MR CLEAN 
trial) 348 
Anterior 
circulation 
stroke 
Ga vs  
non-GA 
GA associated with worse 
outcomes 
• Retrospective and non-
randomized nature - 
Possible selection bias 
• Inequality in group sizes 
(non-GA 278 vs. GA 70) 
Davis [30] 
2012 
Retrospective, 
monocentric 96 
Large vessel 
occlusion 
GA vs LA (with or 
without CS, as 
needed) 
GA associated with: 
- worse outcomes 
- higher mortality 
• Retrospective and non-
randomized nature 
• GA - more severe strokes 
Nichols [31] 
2010 
Retrospective, 
multicentric 
(13 centers; 
cohort from 
IMS II Study) 75 
Anterior 
circulation 
stroke 
No sedation, mild 
sedation, heavy 
sedation, 
pharmacological 
paralysis 
Mild or no sedation associated 
with: 
- higher rate of good outcomes 
- lower mortality 
- higher angiographic 
reperfusion rates 
• Retrospective and non-
randomized nature 
• Small sample size 
• Baseline NIHSS varied 
significantly between 
different levels of sedation 
(higher in deeper sedation 
categories) 
John [16] 
2014 
Retrospective, 
monocentric 190 
Anterior 
circulation 
stroke GA vs MAC 
GA associated with: 
- higher mortality 
- higher rate of parenchymal 
hematomas 
No statistical difference in 
outcomes between groups 
• Retrospective and non-
randomized nature - 
Possible selection bias 
Li [36] 
2014 
Retrospective, 
monocentric 109 
Anterior, 
middle and 
posterior 
circulation 
strokes GA vs CS 
GA associated with: 
- higher mortality 
- longer door-to-recanalization 
time 
• Retrospective and non-
randomized nature 
• Small sample size 
• Lack of long-term clinical 
follow-up at 90 days 
Sugg [32] 
2010 
Retrospective, 
monocentric 66 
Anterior, 
middle and 
posterior 
circulation 
strokes 
GA vs  
non-anesthetized 
Nonanesthetized associated 
with: 
- better outcome 
- lower complication rate 
• Retrospective and non-
randomized nature 
• Small sample size  
• GA - older and higher 
baseline NIHSS scores 
Just [39] 
2016 
Retrospective, 
monocentric 109 
Anterior, 
middle and 
posterior 
circulation 
strokes GA vs CS 
GA associated with: 
- higher mortality at hospital 
discharge, 3 months and 6 
months poststroke onset 
- greater morbidity 
• Retrospective and non-
randomized nature 
• long duration of the study 
(2000-2013) - technology 
and technique have evolved 
significantly over the course 
of the study 
• Did not study hypotension 
Schonenberger 
[10] 
2016 
Prospective, 
monocentric 150 
Anterior 
circulation 
stroke GA vs CS 
No statistical difference in 
primary outcome (early 
neurological improvement) 
No difference in mortality 
• Single center 
• Anesthesiologists more 
experienced on GA 
• Small sample size 
[ ], Citation; CS, Conscious Sedation; GA, General Anesthesia; LA, Local Anesthesia; MAC, Monitored Anesthesia Care; NIHSS, National 
Institutes of Health Stroke Scale 
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artigo e de seus autores), Cover Letter (carta de apresentação do artigo ao Editor), e Author Agreement (declaração de ineditismo 
e não submissão e/ou publicação duplicada); figuras em barras ou linhas XLS (padrão Excel); e fotos e figuras, com resolução mínima 
de 300 dpi, em formato JPG. Não inserir títulos e legendas nas ilustrações. Não inserir ilustrações no corpo do texto. Cada ilustração 
deve ter arquivo individual. O nome dos arquivos deve expressar o tipo e a numeração da ilustração (Figura 1, Tabela II, por exemplo). 
Títulos e legendas das ilustrações, devidamente numerados, devem estar no arquivo de texto. Cópias ou reproduções de outras 
publicações serão permitidas apenas mediante a anexação de autorização expressa da Editora ou do Autor do artigo de origem.
Abreviaturas: As abreviaturas não são recomendáveis, exceto as reconhecidas pelo Sistema Internacional de Pesos e Medidas, ou 
aquelas consignadas e consagradas nas publicações médicas. Quando as abreviaturas forem em grande número e relevantes utilizar 
suas definições (Glossário), em nota à parte. 
Abreviaturas de termos consagrados pela Medicina deverão seguir as normas internacionais tradicionalmente em uso, de acordo com 
as abreviaturas padrões aprovadas pelo documento de Montreal, publicado no British Medical Journal, 1979;1:532-535.
Nomes de Fármacos: Não é recomendável a utilização de nomes comerciais de  fármacos (marca registrada), mas quando a utilização 
for imperativa, o nome do  produto deverá vir após o nome genérico, entre parênteses, em minúscula, seguido do símbolo que 
caracteriza marca registrada, em sobrescrito (®). 
Considerações Éticas e Legais: de acordo com Exigências para Manuscritos Submetidos a Revistas da área Biomédica (Comitê 
Internacional de Editores de Revistas Médicas – Fevereiro de 2006).
Conflito de Interesses
O conflito de interesses existe quando um autor (ou a instituição do autor), revisor, ou editor tem relações de financiamento ou pessoais 
que influenciem de forma negativa (viés) suas ações. Essas relações variam desde com potencial mínimo até de grande potencial de 
influência sobre o julgamento, e nem todas representam conflito de interesses verdadeiro. O potencial para conflito de interesses pode 
existir se um indivíduo acredita ou não que suas relações afetam ou podem influenciar negativamente a credibilidade da revista, dos 
autores, ou da própria ciência. Entretanto conflitos podem ocorrer por outras razões, como relações pessoais, competição acadêmica e 
intelectual. Com isso, torna-se obrigatório o Author Agreement assinado por todos os autores.
Consentimento Livre e Esclarecido
Os pacientes têm direito à privacidade que não deve ser infringida sem consentimento livre e esclarecido. A identificação de informação, 
incluindo iniciais dos nomes dos pacientes, número de registro do hospital, não deve ser publicada através de descrições no texto, 
fotografias ou qualquer outra modalidade, a menos que ela seja essencial para os propósitos científicos e o paciente (ou responsável) 
forneça consentimento por escrito para publicação. O consentimento livre e esclarecido para esta finalidade exige que o paciente veja o 
manuscrito que será publicado. Os autores devem identificar indivíduos que deram assistência na elaboração do texto e declarar a origem 
dos fundos para essa assistência.
Detalhes que facilitem a identificação devem ser omitidos se não forem essenciais. O anonimato completo é difícil de ser atingido, 
entretanto consentimento livre e esclarecido deve ser obtido se existir qualquer dúvida. Por exemplo, mascarar a região dos olhos 
em fotografia de pacientes é uma proteção inadequada para o anonimato. Se características de identificação forem alteradas para 
garantir o anonimato, os autores devem garantir que essas alterações não provocarão distorção do significado científico. 
Quando o consentimento livre e esclarecido for obtido esta informação deve constar da publicação.
Ética
Quando estudos em humanos são publicados, os autores devem indicar se os procedimentos obedeceram aos padrões éticos do comitê 
de pesquisa em humanos (institucional ou nacional) e a Declaração de Helsinki de 1975, revista em 2000. Se existirem dúvidas quanto à 
condução de acordo com os padrões da Declaração de Helsinki, os autores devem explicar o racional para o procedimento e demonstrar 
que a comissão institucional responsável aprovou explicitamente os aspectos duvidosos do estudo. Quando a publicação for relativa 
à pesquisa com animais os autores devem indicar se foram obedecidas as normas de cuidados institucionais ou nacionais e o uso de 
animais de laboratório foi seguido.
Registro de Ensaio Clínico
Ensaios clínicos deverão ser registrados de acordo com orientação da OMS no endereço www.who.int/ictrp/en/. A OMS considera ensaios 
clínicos inclusive ensaios preliminares (fase I), qualquer estudo que recrute prospectivamente sujeitos de pesquisa para serem submetidos 
a intervenções relacionadas à saúde (fármacos, procedimentos cirúrgicos, aparelhos, terapias comporta men tais, dietas, modificações 
nos cuidados de saúde) com finalidade de avaliar os efeitos sobre desfechos clínicos (qualquer variável biomédica ou relacionada com a 
saúde, inclusive medidas farmacocinéticas e efeitos adversos). 
A revista tem o direito de não publicar estudos clínicos que não estejam de acordo com estes e outros padrões éticos determinados 
por diretrizes internacionais.
